GSK’s $1.9 billion takeover of Sierra Oncology has delivered the first new product, with the EU approval of Omjjara for the treatment of enlarged spleen (splenomegaly) or symptoms in adult ...

the company provides fedratinib according to the commercial arrangement. This recommendation is not intended to affect treatment with fedratinib that was started in the NHS before this guidance was ...

FibroBiologics Files Patent Application for a Cell-based Therapeutic for the Treatment Of Splenomegaly ...

FibroBiologics (FBLG) announced the filing of a patent application covering methods for treatment of splenomegaly using a cell-based ...